Market open· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Rx revenue in Germany is now expected at EUR 730 to 760 million for full-year 2026, up from the previously guided range of EUR 680 to 720 million. Full-year 2026 total revenue growth guidance rose to 16% to 18%, from 15% to 17% previously. Non-R...
Investing.com -- Jefferies sees improving prospects across European midcaps heading into the second half of 2026, pointing to stronger order intake, improving momentum and greater earnings visibility after a broadly positive second-quarter reporting season.
Redcare Pharmacy NV (SHPPF) reports robust revenue growth and improved EBITDA margins, while navigating market competition and regulatory changes.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.